Antiangiogenic effect of combined treatment with curcumin and genistein on human prostate cancer cell line

Journal of Functional Foods

Volumn 8, Issue 1, 2014, Pages 204-213

  Aditya, N P ^a   Shim, Myeongkuk ^a   Yang, Hanjoo ^a   Lee, YoungJoo ^a   Ko, Sanghoon ^a  

^a Sejong University   (South Korea)

Author keywords

Angiogenesis; Combination; Curcumin; Genistein; Prostate cancer

Indexed keywords

EID: 84899927059     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2014.03.014     Document Type: Article

References (24)

1. Aditya N.P., Shim M., Lee I., Lee Y., Im M.H., Ko S. Curcumin and genistein coloaded nanostructured lipid carriers: In vitro digestion and antiprostate cancer activity. Journal of Agricultural and Food Chemistry 2013, 61:1878-1883.
2. Baade P.D., Youlden D.R., Krnjacki L.J. International epidemiology of prostate cancer: Geographical distribution and secular trends. Molecular Nutrition & Food Research 2009, 53:171-184.
3. Beevers C.S., Li F.J., Liu L., Huang S.L. Curcumin inhibits the mammalian target of rapamycin-mediated signaling pathways in cancer cells. International Journal of Cancer 2006, 119:757-764.
4. Darrington E., Zhong M., Vo B.H., Khan S.A. Vascular endothelial growth factor A, secreted in response to transforming growth factor-beta1 under hypoxic conditions, induces autocrine effects on migration of prostate cancer cells. Asian Journal of Andrology 2012, 14:745-751.
5. Dhar S., Kolishetti N., Lippard S.J., Farokhzad O.C. Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:1850-1855.
6. Gururaj A.E., Belakavadi M., Venkatesh D.A., Marme D., Salimath B.P. Molecular mechanisms of anti-angiogenic effect of curcumin. Biochemical and Biophysical Research Communications 2002, 297:934-942.
7. Herman-Antosiewicz A., Singh S.V. Checkpoint kinase 1 regulates diallyl trisulfide-induced mitotic arrest in human prostate cancer cells. The Journal of Biological Chemistry 2005, 280:28519-28528.
8. Hilchie A.L., Furlong S.J., Sutton K., Richardson A., Robichaud M.R.J., Giacomantonio C.A., Ridgway N.D., Hoskin D.W. Curcumin-induced apoptosis in PC3 prostate carcinoma cells is caspase-independent and involves cellular ceramide accumulation and damage to mitochondria. Nutrition and Cancer 2010, 62:379-389.
9. Ide H., Tokiwa S., Sakamaki K., Nishio K., Isotani S., Muto S., Hama T., Masuda H., Horie S. Combined inhibitory effects of soy isoflavones and curcumin on the production of prostate-specific antigen. The Prostate 2010, 70:1127-1133.
10. Ide H., Yu J., Lu Y., China T., Kumamoto T., Koseki T., Muto S., Horie S. Testosterone augments polyphenol-induced DNA damage response in prostate cancer cell line, LNCaP. Cancer Science 2011, 102:468-471.
11. Im K., Ravi A., Kumar D., Kuttan R., Maliakel B. An enhanced bioavailable formulation of curcumin using fenugreek-derived soluble dietary fibre. Journal of Functional Foods 2012, 4:348-357.
12. Levy A.P., Levy N.S., Goldberg M.A. Post-transcriptional regulation of vascular endothelial growth factor by hypoxia. The Journal of Biological Chemistry 1996, 271:2746-2753.
13. Lim W., Park Y., Cho J., Park C., Park J., Park Y.K., Park H., Lee Y. Estrogen receptor beta inhibits transcriptional activity of hypoxia inducible factor-1 through the downregulation of arylhydrocarbon receptor nuclear translocator. Breast Cancer Research 2011, 13. R32.
14. Mak P., Leav I., Pursell B., Bae D., Yang X., Taglienti C.A., Gouvin L.M., Sharma V.M., Mercurio A.M. ERβ impedes prostate cancer EMT by destabilizing HIF-1α and inhibiting VEGF-mediated snail nuclear localization: Implications for Gleason grading. Cancer Cell 2010, 17:319-332.
15. Maltepe E., Schmidt J.V., Baunoch D., Bradfield C.A., Simon M.C. Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT. Nature 1997, 386:403-407.
16. Niu Y.J., Altuwaijri S., Lai K.P., Wu C.T., Ricke W.A., Messing E.M., Yao J., Yeh S., Chang C. Androgen receptor is a tumor suppressor and proliferator in prostate cancer. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:12182-12187.
17. Park C., Kim Y., Shim M., Lee Y. Hypoxia enhances ligand-occupied androgen receptor activity. Biochemical and Biophysical Research Communications 2012, 418:319-323.
18. Piccolella M., Crippa V., Messi E., Tetel M.J., Poletti A. Modulators of estrogen receptor inhibit proliferation and migration of prostate cancer cells. Pharmacological Research 2014, 79:13-20.
19. Siegel R., Ward E., Brawley O., Jemal A. Cancer statistics, 2011: The impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA: A Cancer Journal for Clinicians 2011, 61:212-236.
20. Subramaniam D., Ramalingam S., Linehan D.C., Dieckgraefe B.K., Postier R.G., Houchen C.W., Jensen R.A., Anant S. RNA binding protein CUGBP2/CELF2 mediates curcumin-induced mitotic catastrophe of pancreatic cancer cells. PLoS ONE 2011, 6. e16958.
21. Trottier G., Bostrom P.J., Lawrentschuk N., Fleshner N.E. Nutraceuticals and prostate cancer prevention: A current review. Nature Reviews Urology 2010, 7:21-30.
22. Verma S.P., Salamone E., Goldin B. Curcumin and genistein, plant natural products, show synergistic inhibitory effects on the growth of human breast cancer MCF-7 cells induced by estrogenic pesticides. Biochemical and Biophysical Research Communications 1997, 233:692-696.
23. Vo T.-S., Kim S.-K. Fucoidans as a natural bioactive ingredient for functional foods. Journal of Functional Foods 2013, 5:16-27.
24. Yu X.P., Zhu J.D., Mi M.T., Chen W., Pan Q., Wei M. Anti-angiogenic genistein inhibits VEGF-induced endothelial cell activation by decreasing PTK activity and MAPK activation. Medical Oncology 2012, 29:349-357.